Assessment, prevalence, and correlates of frailty among middle-aged adults with HIV in rural Uganda.


Journal

Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123

Informations de publication

Date de publication:
06 2021
Historique:
received: 16 10 2020
accepted: 09 03 2021
revised: 26 01 2021
pubmed: 1 4 2021
medline: 22 1 2022
entrez: 31 3 2021
Statut: ppublish

Résumé

We investigated the prevalence and risk factors for frailty among people with HIV (PWH) in rural Uganda (n = 55, 47% male, mean age 44 years). Frailty was defined according to the Fried criteria with self-reported physical activity level replacing the Minnesota Leisure Time Activity Questionnaire. Alternate classifications for physical activity utilized were the sub-Saharan Africa Activity Questionnaire and the International Physical Activity Questionnaire. Eleven participants (19%) were frail. Frail participants were older (p < 0.001), less likely to be on antiretroviral therapy (p = 0.03), and had higher rates of depression (p < .001) and HIV-associated neurocognitive disorder (p = 0.003). Agreement between physical activity measures was sub-optimal. Prevalence of frailty was high among PWH in rural Uganda, but larger sample sizes and local normative data are needed.

Identifiants

pubmed: 33788138
doi: 10.1007/s13365-021-00969-x
pii: 10.1007/s13365-021-00969-x
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

487-492

Subventions

Organisme : NINDS NIH HHS
ID : L30 NS088658
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States

Références

Kooij KW, Wit FW, Schouten J et al (2016) HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. AIDS 30:241–250
pubmed: 26684821
Desquilbet L, Jacobson LP, Fried LP et al (2007) HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 62:1279–1286
pubmed: 18000149
Wada NI, Jacobson LP, Margolick JB et al (2015) The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS 29:463–471
pubmed: 25630041
Fried LP, Tangen CM, Walston, J (2001) Frailty in older adults: evidence for a phenotype. J. Gerontol A Biol Sci Med Sci 56 (3) M146–56.
Althoff KN, Jacobson LP, Cranston RD et al (2014) Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci 69:189–198
pubmed: 24127428
Leng SX, Margolick JB (2015) Understanding frailty, ageing, and inflammation in HIV infection. Curr HIV/AIDS Rep 12:25–32
pubmed: 25656346 pmcid: 4751047
Wulunggono W, Yunihastuti E, Shatri H, Wahyudi ER, Ophinni Y (2019) Frailty among HIV-1 infected adults under antiretroviral therapy in Indonesia. Curr HIV Res. [Epub ahead of print]
Smith B, Skolasky R, Selnes O (2012) Association of HIV-associated neurocognitive disorder with frailty in HIV-1-seropositive men, 3rd International workshop on HIV and Aging.
Wallace LM, Ferrara M, Brothers TD et al (2017) Lower frailty is associated with successful cognitive aging among older adults with HIV. AIDS Res Hum Retroviruses 33(2):157–163
pubmed: 27869500 pmcid: 5335777
Womack JA, Goulet JL, Gibert C et al (2013) Physiologic frailty and fragility fracture in HIV-infected male veterans. Clin Infect Dis 56:1498–1504
pubmed: 23378285 pmcid: 3634308
Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M et al (2016) HIV-associated neurocognitive disorder–pathogenesis and prospects for treatment. Nat Rev Neurol 12(4):234–248
pubmed: 26965674 pmcid: 26965674
Pelloquin Regan, Abdo M, MaWhinney S, Jankowski (2020) Physical function and frailty tools in mortality prediction of middle-aged adults with HIV, JAIDS - Volume Publish Ahead of Print
Vance DE, Wadley VG, Crowe MG, Raper JL, Ball KK (2011) Cognitive and everyday functioning in older and younger adults with and without HIV. Clin Gerontol 34(5):413–426
pubmed: 22563140 pmcid: 3342698
Valcour V, Shikuma C, Shiramizu B et al (2004) Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63:822–827
pubmed: 15365130
Goodkin K, Miller EN, Cox C et al (2017) Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study. Lancet HIV 4:e411–e422
pubmed: 28716545 pmcid: 5753579
Sun-Suslow N, Paolillo EW, Morgan EE (2020) Frailty and HIV disease severity synergistically increase risk of HIV-associated neurocognitive disorders, JAIDS. Volume Publish Ahead of Print.
Seider TR, Luo X, Gongvatana A et al (2014) Verbal memory declines more rapidly with age in HIV infected versus uninfected adults. J Clin Exp Neuropsychol 36:356–367
pubmed: 24645772 pmcid: 4317358
Cohen RA, Seider TR, Navia B (2015) HIV effects on age‐associated neurocognitive dysfunction: premature cognitive ageing or neurodegenerative disease? Alzheimers Res Ther, 7:37.Review
Tedaldi EM, Minniti NL, Fischer T (2015) HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Res Int 2015:13
Nasi M, De Biasi S, Gibellini L et al (2017) Ageing and inflammation in patients with HIV infection. Clin Exp Immunol 187:44–52
pubmed: 27198731
Morgello S, Gensler G, Sherman S et al (2019) Frailty in medically complex individuals with chronic HIV. AIDS 33(10):1603–1611
pubmed: 31305330
Saylor D, Kumar A, Nakigozi G et al (2019) Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naive adults in Rakai, Uganda. J Neuroviro, l 25:735–740
Rubin LH, Saylor D, Nakigozi G (2019) Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda. J Neurovirol.
Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ (1977) Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 106(3):203–214
pubmed: 900119
Chelune G, Lehman R (1986) Neuropsychology and personality correlates of patients’ complaints of disability. In: Goldstein G, Tarter R, editors. New York: Plenum Press. p. 95–118.
The clinical evaluation of chemotherapeutic agents in cancer (1949) press release. Columbia University Pres, New York
Price RW, Sidtis J (1993) Evaluation of the AIDS dementia complex in clinical trials. J Acquir Immune Defic Syndr 3:551–560
Saylor DN, Nakigosi G, Nakasujja N, Robertson K, Gray R, Wawer M, Sacktor N (2017) Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda. Neurology. 89(5):485–96.
Taylor HL, Jacobs DR Jr, Schucker B et al (1978) A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 31:741–755
pubmed: 748370
Pathai S et al (2013) Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr 62:43–51
pubmed: 23018372 pmcid: 3772340
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395
Wolin KY, Heil DP, Askew S, Matthews CE, Bennett GG (2008) Validation of the International Physical Activity Questionnaire-Short among Blacks. J Phys Act Health 5(5):746–760
pubmed: 18820348 pmcid: 2744347
Sobngwi E, Mbanya JCN, Unwin NC, Aspray TJ, Alberti KGMM (2001) Development and validation of a questionnaire for the assessment of physical activity in epidemiological studies in sub-Saharan Africa. Int J Epidemiol 30(6):1361–1368
pubmed: 11821347
Sacktor N, Saylor D, Nakigozi G (2019) Effect of HIV subtype and antiretroviral therapy on HIV-associated neurocognitive disorder stage in Rakai, Uganda. J Acquir Immune Defic Syndr 81(2):216–223
pubmed: 30865184 pmcid: 6522269
Biritwum RB, Minicuci N, Yawson AE (2016) WHO SAGE Collaboration. Prevalence of and factors associated with frailty and disability in older adults from China, Ghana, India, Mexico, Russia and South Africa. Maturitas. 91:8–18
Pengpid S, Peltzer K (2019) Prevalence and associated factors of frailty in community-dwelling older adults in Indonesia, 2014–2015. Int J Environ Res Public Health 17(1):10
pmcid: 6981585
Bandeen-Roche K, Xue QL, Ferrucci L et al (2006) Phenotype of frailty: characterization in the women’s health and aging studies. J Gerontol A Biol Sci Med Sci 61:262–266
pubmed: 16567375
Lewis EG, Coles S, Howorth K (2018) The prevalence and characteristics of frailty by frailty phenotype in rural Tanzania. BMC Geriatrics, 10.1186
Gustafson DR, Shi Q, Thurn M et al (2016) Frailty and constellations of factors in aging HIV-infected and uninfected women-the Women’s Interagency HIV Study. J Frailty Aging 5(1):43–48
pubmed: 26980368 pmcid: 4957016
Pathai S, Gilbert C, Weiss HA et al (1999) Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr 2013(62):43–51
Erlandson KM, Allshouse AA, Jankowski CM et al (2013) Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 208:249–259
pubmed: 23559466 pmcid: 3685225
Zhang W, Nilles TL, Johnson JR, Margolick JB (2015) Regulatory T cells, frailty, and immune activation in men who have sex with men in the Multicenter AIDS Cohort Study. J Gerontol A Biol Sci Med Sci 70:1533–1541
pubmed: 26297938 pmcid: 4751226
Ianas V, Berg E, Mohler MJ, Wendel C, Klotz SA (2013) Antiretroviral therapy protects against frailty in HIV-1 infection. J Int Assoc Provid AIDS Care 12:62–66
pubmed: 23042791
Birbeck GL, Kvalsund MP, Byers PA et al (2011) Neuropsychiatric and socioeconomic status impact antiretroviral adherence and mortality in rural Zambia. Am J Trop Med Hyg 85(4):782–789
pubmed: 21976587 pmcid: 3183792
Kvalsund M Chidumayo J,  Hamel T (2018) Factors associated with distal symmetric polyneuropathies in adult Zambians: a cross-sectional, observational study of the role of HIV, non-antiretroviral medication exposures, and nutrition J Neurol Sci. 15(388):61-69
Oppenheim H, Paolillo EW, Moore RC et al (2018) Neurocognitive functioning predicts frailty index in HIV. Neurology 91(2):e162–e170
pubmed: 29875216 pmcid: 6053109
Paul RH, Cooley SA, Garcia-Egan PM et al (2018) Cognitive performance and frailty in older HIV-positive adults. J Acquir Immune Defic Syndr 79:375–380
pubmed: 29957675
Adebusoye LA, Cadmus EO, Owolabi MO, Ogunniyi A (2019) Frailty and mortality among older patients in a tertiary hospital in Nigeria. Ghana Med J 53(3):210–216
pubmed: 31741493 pmcid: 6842731
Vaughan L, Corbin AL, Goveas JS (2015) Depression and frailty in later life: a systematic review. Clin Interv Aging 10:1947–1958
pubmed: 26719681 pmcid: 4687619
Kirkness C, Ren J (2015) Race differences: Use of walking speed to identify community-dwelling women at risk for poor health outcomes – Osteoarthritis Initiative Study. Phys Ther 95:955–965
pubmed: 25655879 pmcid: 4498144
Capistrant BD, Glymour MM, Berkman LF (2014) Assessing mobility differences for cross-national comparisons: results from the WHO Study on AGEing and Adult Health. J Am Geriatr Soc 62:329–335
pubmed: 24438515 pmcid: 3945402
Dodds RM, Syddall HE, Cooper R et al (2016) Global variation in grip strength: a systematic review and meta-analysis of normative data. Age Ageing 45:209–216
pubmed: 26790455 pmcid: 4776623
Leong DP, Teo KK, Rangarajan S et al (2016) References ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) study. J Cachexia Sarcopenia Muscle 7:536–546
Espinoza SE, Hazuda HP (2008) Frailty in older Mexican-American and European American adults: is there an ethnic disparity? J Am Geriatr Soc 56:1744–1749
pubmed: 18662198
Gureje O, Oladeji BD, Abiona T, Chatterji S (2014) Profile and determinants of successful aging in the Ibadan study of ageing. J Am Geriatr Soc 62(5):836–842
pubmed: 24801657 pmcid: 4371130

Auteurs

Alyssa Vecchio (A)

University of North Carolina-Chapel Hill, Chapel Hill, NC, USA. alyssacv@med.unc.edu.

Gertrude Nakigozi (G)

Makerere University, Kampala, Uganda.

Noeline Nakasujja (N)

Rakai Health Sciences Program, Kalisizo, Uganda.

Alice Kisakye (A)

Rakai Health Sciences Program, Kalisizo, Uganda.

James Batte (J)

Rakai Health Sciences Program, Kalisizo, Uganda.

Richard Mayanja (R)

Rakai Health Sciences Program, Kalisizo, Uganda.

Aggrey Anok (A)

Rakai Health Sciences Program, Kalisizo, Uganda.

Kevin Robertson (K)

University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.

Maria J Wawer (MJ)

Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.

Ned Sacktor (N)

Johns Hopkins University School of Medicine, Baltimore, USA.

Leah H Rubin (LH)

Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
Johns Hopkins University School of Medicine, Baltimore, USA.

Deanna Saylor (D)

Johns Hopkins University School of Medicine, Baltimore, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH